Trials / Completed
CompletedNCT04751162
A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.
An Observational Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current research is a non-interventional (NIS) study seeking to support objective Performance Status (PS) assessments in the particular context of metastatic NSCLC adult patients. To do so, the study comprises two phases. Phase I addresses a feasibility mixed-methods (quantitative-qualitative) approach. It primarily focuses on examining perceived technology usability in a limited sample of participants and feasibility of translating the actigraph data into PS scores (focus expert group). Phase II focuses on to primarily examine associations between technology collected data and ECOG-PS in a larger sample of participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Actigraphy device (wearable) and mobile application | Participants will be asked to wear an actigraphy device (wearable) and to install a mobile application on their smartphones (cf. Broderick et al., 2019) for tracking PA, SQ and symptoms for 3 weeks |
Timeline
- Start date
- 2021-02-18
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
- First posted
- 2021-02-11
- Last updated
- 2023-06-18
Locations
10 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT04751162. Inclusion in this directory is not an endorsement.